Jade Biosciences Q3 EPS $(0.42) Beats $(0.71) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.71) by 40.85 percent. This is a 12.5 percent increase over losses of $(0.48) per share from
Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.71) by 40.85 percent. This is a 12.5 percent increase over losses of $(0.48) per share from the same period last year.